Lexeo Therapeutics, Inc.
LXEO
$4.84
-$0.12-2.42%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 59.30% | 93.37% | 49.58% | -21.82% | -24.05% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -31.58% | 43.65% | 43.93% | 106.28% | 230.67% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 55.58% | 90.80% | 49.37% | -19.86% | -20.94% |
|
|
|||||
| Total Current Assets | 55.58% | 90.80% | 49.37% | -19.86% | -20.94% |
| Net Property, Plant & Equipment | -19.18% | -17.64% | -16.10% | -15.62% | -15.95% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | -0.12% | -0.12% | -0.12% |
| Total Assets | 44.77% | 99.19% | 82.85% | -17.27% | -8.30% |
|
|
|||||
| Total Accounts Payable | -79.13% | -72.16% | -24.33% | -44.82% | 247.35% |
| Total Accrued Expenses | -1.66% | -48.11% | -30.35% | -36.01% | -14.64% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.38% | 1.81% | 0.19% | 1.23% | -0.52% |
| Total Finance Division Other Current Liabilities | 43.01% | -84.60% | -86.61% | -62.27% | -15.45% |
| Total Other Current Liabilities | 43.01% | -84.60% | -86.61% | -62.27% | -15.45% |
| Total Current Liabilities | -50.33% | -53.97% | -26.43% | -35.60% | 67.36% |
|
|
|||||
| Total Current Liabilities | -50.33% | -53.97% | -26.43% | -35.60% | 67.36% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -33.75% | -30.84% | -28.16% | -25.63% | -23.53% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -47.59% | -49.81% | -26.85% | -33.37% | 39.88% |
|
|
|||||
| Common Stock & APIC | 38.64% | 57.60% | 57.79% | 21.95% | 22.44% |
| Retained Earnings | -25.75% | -27.97% | -35.68% | -41.28% | -50.80% |
| Treasury Stock & Other | -950.00% | -123.94% | 242.50% | 653.85% | -130.77% |
| Total Common Equity | 70.07% | 162.72% | 111.11% | -13.27% | -16.21% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 70.07% | 162.72% | 111.11% | -13.27% | -16.21% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 70.07% | 162.72% | 111.11% | -13.27% | -16.21% |
|
|
|||||